You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Eugia US LLCFDAMed source confidence · 80%Jun 22, 2026, 6:17 PM UTC · 15d ago

Eugia US LLC — FDA Class III (D-0552-2026)

Case File

Eugia US LLC is recalling 168,300 vials of a human prescription drug due to labeling issues. This recall is classified as a voluntary action. The affected product is intended for epidural, infiltration, and intra-articular use.

Sign in to follow Eugia US LLC and get alerts like this
Key Points
  • Eugia US LLC is recalling 168,300 vials of a human prescription drug.
  • The recall is due to mislabeling issues.
  • The drug is administered via epidural, infiltration, or intra-articular routes.
  • Patients should check their medicine cabinets for the recalled vials.
Why This Matters

Patients who received this drug should verify if they have the recalled vials. The recall affects 168,300 vials due to labeling issues.

View original filing →
Sign in to follow Eugia US LLC and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.